Bank of America’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,407
| Closed | -$17K | – | 8632 |
|
|
2022
Q2 | $17K | Sell |
5,407
-1,185
| -18% | -$4.62K | ﹤0.01% | 7236 |
|
|
2022
Q1 | $28K | Sell |
6,592
-7,564
| -53% | -$33K | ﹤0.01% | 7401 |
|
|
2021
Q4 | $66K | Sell |
14,156
-5,626
| -28% | -$23.4K | ﹤0.01% | 7082 |
|
|
2021
Q3 | $79K | Sell |
19,782
-14,524
| -42% | -$57.6K | ﹤0.01% | 6849 |
|
|
2021
Q2 | $147K | Sell |
34,306
-18,094
| -35% | -$77.5K | ﹤0.01% | 6293 |
|
|
2021
Q1 | $222K | Buy |
52,400
+26,004
| +99% | +$143K | ﹤0.01% | 5966 |
|
|
2020
Q4 | $102K | Buy |
26,396
+14,784
| +127% | +$63.2K | ﹤0.01% | 5981 |
|
|
2020
Q3 | $46K | Sell |
11,612
-4,512
| -28% | -$18.7K | ﹤0.01% | 6044 |
|
|
2020
Q2 | $69K | Sell |
16,124
-322
| -2% | -$1.96K | ﹤0.01% | 5843 |
|
|
2020
Q1 | $69K | Sell |
16,446
-4,604
| -22% | -$29.1K | ﹤0.01% | 5724 |
|
|
2019
Q4 | $84K | Buy |
21,050
+6,438
| +44% | +$38K | ﹤0.01% | 6071 |
|
|
2019
Q3 | $129K | Sell |
14,612
-1,425
| -9% | -$13.5K | ﹤0.01% | 5923 |
|
|
2019
Q2 | $149K | Buy |
16,037
+450
| +3% | +$3.39K | ﹤0.01% | 5798 |
|
|
2019
Q1 | $100K | Sell |
15,587
-40,359
| -72% | -$263K | ﹤0.01% | 5882 |
|
|
2018
Q4 | $527K | Buy |
55,946
+5,353
| +11% | +$80.5K | ﹤0.01% | 4893 |
|
|
2018
Q3 | $1.02M | Sell |
50,593
-30,566
| -38% | -$799K | ﹤0.01% | 4473 |
|
|
2018
Q2 | $2.37M | Buy |
81,159
+33,280
| +70% | +$1.03M | ﹤0.01% | 3842 |
|
|
2018
Q1 | $1.43M | Buy |
47,879
+17,631
| +58% | +$568K | ﹤0.01% | 4129 |
|
|
2017
Q4 | $973K | Sell |
30,248
-19,147
| -39% | -$626K | ﹤0.01% | 4506 |
|
|
2017
Q3 | $1.72M | Buy |
49,395
+49,294
| +48,806% | +$1.59M | ﹤0.01% | 4105 |
|
|
2017
Q2 | $2K | Sell |
101
-2,380
| -96% | -$68.2K | ﹤0.01% | 6787 |
|
|
2017
Q1 | $74K | Sell |
2,481
-27,620
| -92% | -$705K | ﹤0.01% | 5760 |
|
|
2016
Q4 | $528K | Buy |
30,101
+1,239
| +4% | +$23.8K | ﹤0.01% | 4763 |
|
|
2016
Q3 | $687K | Buy |
28,862
+28,010
| +3,288% | +$528K | ﹤0.01% | 4414 |
|
|
2016
Q2 | $13K | Buy |
852
+827
| +3,308% | +$14.8K | ﹤0.01% | 6423 |
|
|
2016
Q1 | $1K | Sell |
25
-485
| -95% | -$8.65K | ﹤0.01% | 6940 |
|
|
2015
Q4 | $14K | Buy |
510
+469
| +1,144% | +$12.8K | ﹤0.01% | 6583 |
|
|
2015
Q3 | $1K | Sell |
41
-276
| -87% | -$8.7K | ﹤0.01% | 7154 |
|
|
2015
Q2 | $8K | Buy |
+317
| New | +$6.53K | ﹤0.01% | 6693 |
|
Bank of America's LJPC Position: Q3 2022 in Review
Bank of America sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 5,407 shares — an estimated $17K sold.
Bank of America first reported a position in LJPC in Q2 2015 and held it in 29 quarters. The position peaked at $2.37M in Q2 2018. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Bank of America reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Bank of America sold 5,407 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $17K.
- Bank of America first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 29 quarters.
- Bank of America's La Jolla Pharmaceutical Company position peaked at $2.37M in Q2 2018.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Bank of America's 13F filing for Q3 2022, filed 14 Nov 2022.